Sanofi sues Merck over Lantus patents

21-09-2016

Sanofi sues Merck over Lantus patents

Copyright © 2009-2014 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A. All rights reserved.

Sanofi has filed a complaint against Merck for allegedly infringing ten of its patents centring on the diabetes drugs Lantus (insulin glargine injection) and Lantus SoloSTAR.


Sanofi, Merck, Lantus, Lantus SoloStar, patent, NDA

More on this story

Sanofi takes on Mylan over diabetes injection
25-10-2017

LSIPR